FTC Announces Enforcement Action Against 1Health.io for Inadequate Protection of Genetic Data and Unfair Privacy Policy Changes

On June 16, the Federal Trade Commission (FTC) announced an enforcement action against 1Health.io Inc. (“1Health,” also known as Vitagene, Inc.), a genetic testing company that analyzes consumer-provided DNA samples and uses the results of that analysis to generate personalized reports and other tailored products….
By: WilmerHale
Previous Story

Explainer Things: Episode 6

Next Story

FDA Announces Draft Guidance on Outsourcing Facility Sales